Similar real-world two-year visual acuity gains in treatment-naive patients with diabetic macular oedema treated with a loading dose of three initial monthly injections versus less intensive regimens of intravitreal anti-vascular endothelial growth factor

Johanne Bjerre Lindboe*, Caroline Schmidt Laugesen, Torben Lykke Sørensen, Troels Brynskov

*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskriftLetterForskningpeer review

OriginalsprogEngelsk
Sider (fra-til)e1248-e1249
TidsskriftActa ophthalmologica
Vol/bind99
Udgave nummer7
Tidlig onlinedato6 maj 2021
DOI
StatusUdgivet - nov. 2021

Citationsformater